Evofem Biosciences, Inc.
EVFM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,569 | -$1,784 | $956 | -$3,037 |
| Dep. & Amort. | $23 | $135 | $266 | $361 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $23 | $31 | $70 | $188 |
| Change in WC | -$3,541 | -$1,758 | $5,299 | -$2,474 |
| Other Non-Cash | $5,400 | $457 | -$6,031 | $2,554 |
| Operating Cash Flow | $336 | -$2,919 | $560 | -$2,408 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2 | $0 | $0 |
| Net Acquisitions | $57 | $0 | -$57 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$46 |
| Investing Cash Flow | $57 | -$2 | -$57 | -$46 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $2,560 | -$135 | -$267 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$1 | -$3 | $0 |
| Other Fin. Act. | -$133 | $1 | $3 | $5,515 |
| Financing Cash Flow | -$244 | $2,560 | -$135 | $2,473 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $92 | -$361 | $368 | $19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $748 | $1,109 | $741 | $722 |
| End Cash | $840 | $748 | $1,109 | $741 |
| Free Cash Flow | $336 | -$2,921 | $560 | -$2,408 |